The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Sanofi Q1 2013 - Interview with CFO Jérôme Contamine

Thursday, May 02, 2013

Sanofi Q1 2013 - Interview with CFO Jérôme Contamine

01:45 EDT Thursday, May 02, 2013

PARIS (Business Wire) -- Sanofi, a global and diversified healthcare leader, reports earnings for the first-quarter of 2013. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on results and outlook.

Click to watch the video: http://bit.ly/101e4XC

Topics covered in the interview include:

- Performance

- Guidance

- Emerging Markets

- Diabetes

- Rare Diseases

- Multiple Sclerosis

- R&D Pipeline

- Capital Allocation

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Company website: www.sanofi.com

Sanofi
Investor Relations
Sébastien Martel, +33 1 53 77 45 45
IR@sanofi.com
or
Media Relations
+33 1 53 77 45 02
MR@sanofi.com

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections